8-K · ABBV
AbbVie files an 8-K on director or officer changes
AbbVie filed a Form 8-K on Nov 2, 2026 at 4:05 PM ET under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).
Under Item 5.02, the filing says: “Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers On October 28, 2026, Jennifer L. Davis, a Class II director of AbbVie Inc. (“AbbVie”), notified the Company’s Board of Directors (the “Board”), of her intent to resign from …”
Source
- 8-K filed Nov 2, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
AbbVie company file → · More AbbVie filings
Disclosures
- Editor holdings in ABBV
- The editor holds no position in AbbVie (ABBV). As of Nov 11, 2026.
- Last updated
- Nov 2, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold ABBV.